Archives for March 20, 2014

DISPATCHES FROM INTERPHEX

Patheon and DSM crossover limited, more growth targeted says DPx

Patheon and DSM’s Pharma Products merger is “highly complementary” with crossover limited to North American oral solid manufacturing growth, says DPx as it targets further growth opportunities.

UK MHRA scheme will allow compassionate use of unlicensed drugs

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) will launch a scheme next month to allow doctors to prescribe medicines without a marketing authorisation to patients with life-threatening conditions.

Drug firms replaced as Lonza's biggest buyers in 2013

Drugmakers were replaced by buyers of cosmetics, hygiene and material protection ingredients as Lonza’s biggest customers in 2013 according to a report released by the Swiss CMO today.

UK energy cuts good for pharma, API and chem firms says industry group

Efforts to cut industrial energy bills in the UK's 2014 Budget have been welcomed by the Chemical Industries Association (CIA), a group whose members include drug and ingredient makers.